| Product Code: ETC10765632 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Malta pemetrexed import shipments in 2024 continued to see a high level of concentration, with the top exporting countries being India, Israel, Ireland, Germany, and Belgium. The Herfindahl-Hirschman Index (HHI) remained at a high level, indicating a concentrated market. The compound annual growth rate (CAGR) from 2020 to 2024 was a healthy 10.1%, demonstrating consistent growth in demand for pemetrexed. Notably, there was a significant growth spike from 2023 to 2024 with a growth rate of 29.61%, indicating a potential surge in demand or supply chain dynamics impacting the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Pemetrexed Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Pemetrexed Market - Industry Life Cycle |
3.4 Malta Pemetrexed Market - Porter's Five Forces |
3.5 Malta Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Malta Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Malta Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Malta Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Malta Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Malta Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malta Pemetrexed Market Trends |
6 Malta Pemetrexed Market, By Types |
6.1 Malta Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Malta Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Malta Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Malta Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Malta Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Malta Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Malta Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Malta Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Malta Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Malta Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Malta Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Malta Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Malta Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Malta Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Malta Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Malta Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Malta Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Malta Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Malta Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Malta Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Malta Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Malta Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Malta Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Malta Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Malta Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Malta Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Malta Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Malta Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Malta Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Malta Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Malta Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Malta Pemetrexed Market Import-Export Trade Statistics |
7.1 Malta Pemetrexed Market Export to Major Countries |
7.2 Malta Pemetrexed Market Imports from Major Countries |
8 Malta Pemetrexed Market Key Performance Indicators |
9 Malta Pemetrexed Market - Opportunity Assessment |
9.1 Malta Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Malta Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Malta Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Malta Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Malta Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Malta Pemetrexed Market - Competitive Landscape |
10.1 Malta Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Malta Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here